Uncategorized


November 19, 2026

AI Regulation: Export Controls Likely, Federal Legislation Limited, But States Moving Ahead

By Joe Lieber

While the Jensen Huang controversy has clearly increased pressure on Congress and state legislatures to impose additional restrictions on AI, we continue to doubt Congress will enact comprehensive AI legislation in 2027, even with Democrats…

Read More >>

November 18, 2026

Trump’s Trade Policy After the Midterms: What Changes and What Doesn’t

By Joe Lieber

Despite the drubbing Republicans took in the November 3 midterm elections, we doubt President Donald Trump is preparing to abandon his tariff agenda. We would not be surprised by a 60- to 90-day pause before…

Read More >>

November 17, 2026

[HUM, UNH, CVS, ELV, CNC, ALHC, CLOV] Medicare Advantage: CMS Doubles Down on RADV in CRUSH; Litigation Far From Settled

By Beth Steindecker

CMS’s latest Medicare Advantage (MA) risk adjustment data validation (RADV) proposal, included in Monday’s Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) proposed rule, largely resurrects the controversial policies it finalized in 2023 that a federal…

Read More >>

November 16, 2026

CRUSH: Dx Clearing Event, DME on Notice

By John Leppard

We view CMS’s formal CRUSH proposal as a clearing event for diagnostics (Dx) manufacturers [TEM, GH, NTRA, CSTL, CAI, CDNA] amid fears that the agency might expand the MolDx program nationwide, institute some manner of…

Read More >>

November 16, 2026

Capitol Policy Weekly: Semiconductor Export Controls, China Trade, Vietnam Tariffs and Permitting Reform

By Joe Lieber

The House and Senate are back in Washington this week, with the Senate returning today and the House tomorrow. Congress faces a crowded lame-duck agenda, including the National Defense Authorization Act (NDAA), permitting reform and…

Read More >>

November 15, 2026

[CNC, MOH, HCA, THC, UHS] Medicaid Work Requirements: Could CMS Reprieve Open Door to Further Delays?

By Beth Steindecker

CMS’s decision, announced late Friday, to offer states a six-month reprieve from Medicaid expansion work and community engagement (CE) requirement-related coverage denials and disenrollments is meaningfully favorable to Medicaid insurers [CNC, MOH, ELV] and acute…

Read More >>

November 12, 2026

ABT: Cologuard+ Rates to Get Worse Before Getting (Way) Better?

By John Leppard

We suspect CMS will finalize a ~15% rate cut for ABT’s Cologuard Plus (CG+) in CY27 through its early Dec. PAMA release, and potentially set the stage for another ~20% drop 2028-2029. In either scenario,…

Read More >>

November 11, 2026

(ASML, TOELF, NVDA, AMD) NDAA: 65% Chance Congress Adopts Three Semiconductor Export Control Measures

By Joe Lieber

We now assign 65% odds the MATCH Act, Chip Security Act, and the AI OVERWATCH Act all become law before Christmas, potentially imposing significant new restrictions on semiconductor equipment and advanced AI chip exports to…

Read More >>

November 9, 2026

[UNH, CI, CVS, ELV, HUM] Healthcare Conglomerates: Democratic Sweep Heightens Breakup Risk but Doesn’t Fully Remove Hurdles

By Beth Steindecker

The prospects for federal legislation forcing health insurers and pharmacy benefit managers (PBMs) [UNH, CI, CVS, ELV, HUM] to divest their pharmacies or healthcare providers have increased following Democrats’ sweeping midterm victories. While we expected…

Read More >>

November 9, 2026

Capitol Policy Weekly: Congress Returns, Permitting Reform, Chip Export Controls, the NDAA and the Lame Duck

By Joe Lieber

The House and Senate return to Washington this week, with members still digesting the ramifications of last Tuesday’s Democratic blowout in the midterm elections. President Trump’s decision to replace Susie Wiles with Stephen Miller as…

Read More >>